CClinicalTrials.gg
Not yet recruitingNCT04039386Updated Apr 15, 2026

Psychosocial Interventions for Young Adults With Hip Pain

An interventional study of Cell Phone Based Cognitive Based Therapy (Pacifica App) and Control in Hip Dysplasia, Hip Pain Chronic and Hip Osteoarthritis, sponsored by Michael C Willey. Not yet recruiting at 1 site in United States. Open to participants aged 15 Years to 39 Years. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Michael C Willey · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
15 Years to 39 Years
Sex
All
01

Study summary

Psychosocial conditions are common in young adults with hip pain including depression, anxiety, pain catastrophizing, and narcotic use. The incidence of these conditions is not well defined. Interventions to optimize psychosocial conditions with non-surgical or surgical treatments has not been investigated. The goal of this project is to determine the incidence of psychosocial conditions in the young adult population with hip pain and determine if cognitive based therapy can improve clinical outcomes in these individuals.

Read the detailed description

Over the last 3 decades there has been a drastic increase in the number of joint preservation surgeries performed for pre-arthritic hip conditions in the United States. Despite advances in surgical technique and the understanding of the biomechanics of impingement and dysplasia, failure rates range from 5-20% at early follow up, and can be even higher with continued monitoring. These failures are often attributed to the presence of pre-operative osteoarthritis, increased age, or unaddressed structural deformity. The influence of psychosocial factors on surgical and rehabilitative outcomes has been recognized in multiple populations, but has largely been ignored in individuals with hip pathology, in spite of growing recognition by clinicians as to how psychosocial factors may contribute to patient outcomes. Previous investigations have demonstrated poor mental health is associated with pre-operative narcotic use and lower physical function. Further, the investigators have identified certain psychiatric diagnoses as independent factors associated with failure of hip arthroscopy. Addressing these often complex psychosocial issues using cognitive based therapy has been successful in improving outcomes across a range of medical conditions. Further investigation into the incidence of these psychosocial conditions, their contributions to surgical and non-surgical outcomes, and interventions for mental health optimization need to be performed in musculoskeletal medicine, specifically in the developing field of hip preservation surgery. The goal of this project is to (1) understand the burden of maladaptive psychosocial traits in young adult patients with hip pain, and (2) reduce pain, decrease narcotic use, and improve physical function through psychosocial intervention delivered concomitantly during physical therapy. The investigators seek to maximize outcomes of individuals with non-arthritic hip dysfunction by addressing maladaptive behaviors so subjects can more effectively participate in rehabilitative treatment, and potentially, avoid the need for surgical management.

02

Conditions studied

  • Hip Dysplasia
  • Hip Pain Chronic
  • Hip Osteoarthritis
  • Hip Arthritis
  • Psychosocial Problem

Keywords

  • Hip Pain
  • Hip Instability
  • Hip Impingement
  • Cognitive Based Therapy
  • Psychosocial Conditions
03

Who can participate

Ages eligible
15 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • We will enroll young adults (15-39) presenting to one of several physical therapy and orthopedic practices in the state of Iowa for treatment of nonarthritic hip pain.
  • Chief complaint of hip pain or dysfunction, and a diagnosis of a nonarthritic hip condition including labral tear, femoroacetabular impingement (FAI), snapping hip, femoral anteversion or dysplasia.

Exclusion criteria

Exclusion Criteria:

  • Exclusion criteria will include age \<15 or >40 years
  • Difficulty with written English
  • Treatment for alternative conditions such as trochanteric bursitis, hip dislocation, avascular necrosis or fracture.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Cell Phone Based Cognitive Based Therapy

    Young adults with hip pain

    Device: Cell Phone Based Cognitive Based Therapy (Pacifica App)

  • Placebo comparator
    Placebo

    Young adults with hip pain

    Other: Control

Interventions

  • DeviceCell Phone Based Cognitive Based Therapy (Pacifica App)

    Cell phone application that provides support for individuals with psychosocial conditions.

  • OtherControl

    Subjects in the control group will receive standard care.

    Also known as: Standard Care

05

What researchers measure

Primary outcomes

  1. Changes in level of Depression (DASS-21)

    Assessed using the Depression Anxiety Stress Scale (DASS-21) electronically administered patient reported outcome questionnaire * General adult population average total score: 9.43 (standard deviation (SD) 9.66), out of a total possible score of 63 points, * Indication of significant difference from normative data: Average score \>1 SD above the General adult population average total score * General adult population average depression sub scale score: 2.83 (SD 3.87) * Values above 9.03 points in the depression subsection score correlate with clinical depression and generalized anxiety disorders * A change of 3.86 or more points in the depression subscore reliably represents clinical improvement.

    Time frame: 8 weeks

  2. Changes in level of Depression (PROMIS)

    Assessed using the Patient Reported Outcome Measures Information (PROMIS): Depression. An electronically administered patient reported outcome questionnaire * Normative T-score generated from US adult population data: mean 50 (SD 10). * For this study, an average T-score \<40 would be considered significantly different compared to normative values. * The minimally important difference (MID) of 3.0-3.1 calculated from research in nonoperative treatment of knee osteoarthritis will be representative of clinical improvement at eight weeks.

    Time frame: 8 weeks

  3. Changes in level of Anxiety (DASS-21)

    Assessed using the Depression Anxiety Stress Scale (DASS-21) electronically administered patient reported outcome questionnaire * General adult population average total score: 9.43 (SD 9.66) * An average total score \>1 SD above the mean would be considered significantly different from normative data * General adult population average anxiety subscale scores: 1.88±2.95 * Average anxiety subsection score above 6.27 correlate with clinical depression and generalized anxiety disorders * A change of 3.85 or more points in the anxiety subscore reliably represents clinical improvement.

    Time frame: 8 weeks

  4. Changes in level of Anxiety (PROMIS)

    Assessed using the Patient Reported Outcome Measures Information (PROMIS): Anxiety. An electronically administered patient reported outcome questionnaire * Normative T-score generated from US adult population data: mean 50 (SD 10). * For this study, an average T-score \<40 would be considered significantly different compared to normative values. * The minimally important difference (MID) of 2.3 to 3.4 calculated from research in nonoperative treatment of knee osteoarthritis will be representative of clinical improvement at eight weeks.

    Time frame: 8 weeks

  5. Changes in level of Stress (DAAS-21)

    Assessed using the Depression Anxiety Stress Scale (DASS-21) electronically administered patient reported outcome questionnaire * General adult population average total score: 9.43 (SD 9.66) * An average total score \>1 SD above the mean would be considered significantly different from normative data * General adult population average stress subscale scores: 4.73±4.20 * Average stress subsection score above 12.27 correlate with clinical depression and generalized anxiety disorders * A change of 4.90 or more points in the anxiety subscore reliably represents clinical improvement.

    Time frame: 8 Weeks

  6. Evaluating the presence and severity of Kinesiophobia

    Assessed via the Shortened Tampa Scale for Kinesiophobia (TSK-11) electronically administered patient reported outcome questionnaire * The survey is a 11-question test scored from 11-44, where higher scores indicate increasing fear of movement. * A value of 11 is presumed in a nonpainful population. * Adults with chronic musculoskeletal pain undergoing outpatient chronic pain therapy report an average TSK score of 30.4 (+/- 6.6). * Successful evaluation of Kinesiophobia will be indicated if increases in TSK-11 scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. * The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding.

    Time frame: 8 weeks

  7. Evaluation of Resiliency

    Assessed via The Brief Resiliency Scale (BRS) electronically administered patient reported outcome questionnaire * An 8 question survey scored from 1-5 points * The average score for US adults age 24-34 is 3.2 (SD 0.7) * A statistically significant lower Grit score would be \>1SD below this average value. * Successful evaluation of Grit will be indicated if increases in GRIT-S scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. * The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding.

    Time frame: 8 weeks

  8. Evaluation of Grit

    Assessed via The Short Grit Scale (GRIT-S) electronically administered patient reported outcome questionnaire * A 6-question test with low resiliency defined as a score of \<3.00. * Prior descriptive studies indicate an average score of 3.57 (SD 0.76) for young adults age 19.8±3.0 years. * Statistically significant lower resilience would be \>1SD below this average value. * Successful evaluation of Resiliency will be indicated if increases in GRIT-S scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. * The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents (for those tests where this data exists) would also be considered a successful finding.

    Time frame: 8 weeks

  9. Evaluating the presence and severity of Pain Catastrophizing

    Assessed via Pain Catastrophizing Scale (PCS) electronically administered patient reported outcome questionnaire * Scored on a 13 point scale. * Normative average values from a population of adults adults age 42.2 (17-63 years) with low back pain: mean 20.90 (SD 12.5), * Successful evaluation of Pain Catastrophization will be indicated if increases in PCS scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. * The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding.

    Time frame: 8 weeks

  10. Evaluating Self-Efficacy

    Assessed via The General Self-Efficacy Scale (GSE) electronically administered patient reported outcome questionnaire * 10-question test, scored from 10-40, with lower scores representing low self efficacy. * Average US adult values: 29.48 (SD 5.13) * Successful evaluation of Self-Efficacy will be indicated if increases in GSE scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. * The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding.

    Time frame: 8 weeks

  11. Evaluating the presence and severity of Alcohol Use Disorders

    Assessed via Alcohol Use Disorders Identification Test (AUDIT) electronically administered patient reported outcome questionnaire * A 10-question test with a threshold score \>7 considered "AUDIT-positive", indicating risky or hazardous alcohol use behavior. * National data suggests 15-20% of US 14-18 year olds screen positive * Successful evaluation of Alcohol Use Disorders will be indicated if increases in AUDIT scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. * The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding.

    Time frame: 8 weeks

  12. Changes in Physical Function (PROMIS)

    Measured via the following electronically administered patient reported outcome questionnaires. * PROMIS: Physical Function (PF) * Normative T-score generated from US adult population data: mean 50 (SD 10). * For this study, an average T-score \<40 would be considered significantly different compared to normative values. * The minimally important difference (MID) of 1.9 - 2.2 calculated from research in nonoperative treatment of knee osteoarthritis will be representative of clinical improvement at eight weeks.

    Time frame: 8 weeks

  13. Changes in Physical Function (HOOS)

    Measured via the following electronically administered patient reported outcome questionnaires. * The Hip disability and osteoarthritis outcome score (HOOS) * Scored from 0-100 * Increasing score represent better function. * Average scopres for hip preservation patients prior to surgery is well established

    Time frame: 8 weeks

  14. Reduced Opioid Use

    Measured via self reported opioid use after surgery

    Time frame: 8 weeks

06

Study locations

1 site
  • University of Iowa
    Iowa City, Iowa 52242, United States
    • Michael C Willey, MD · Contact · michael-willey@uiowa.edu · 3193561616
    • Michael C Willey · Contact · michael-willey@uiowa.edu · 3193561616
    • John Davison, MPH · Sub investigator
    • Elizabeth Scott, MD · Principal investigator
    • Robert Westermann, MD · Sub investigator
    • Michael Willey, MD · Sub investigator
    • Jason Wilken, DPT, PhD · Sub investigator
    • Amanda Paulsen, DPT · Sub investigator
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04039386
Lead sponsor
Michael C Willey
Responsible party
Michael C Willey (Assistant Professor, University of Iowa) — Sponsor-investigator
First posted
Jul 31, 2019
Start date
Sep 1, 2026 (estimated)
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 1, 2028 (estimated)
Last update
Apr 15, 2026

Study contacts

Michael C Willey
Contact
michael-willey@uiowa.edu
3193561616
John Davison, MPH
Contact
john-davison@uiowa.edu
3193846529
Elizabeth Scott, MD
principal investigator · University of Iowa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion